What is Beximco Pharmaceuticals Limited (BXP.L)?

Beximco Pharmaceuticals Limited (BXP.L) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Beximco Pharmaceuticals Limited (BXP.L)

Stock analysis · LSE · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.25

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Beximco Pharmaceuticals Limited (BXP.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Beximco Pharmaceuticals Limited

Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited is a prominent company engaged in the production and distribution of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs). The firm’s extensive product line addresses a wide range of therapeutic areas, including treatments for allergic disorders, pain and fever, various infections (antibacterial and antiviral), cardiovascular conditions, central nervous system ailments, respiratory illnesses, endocrine disorders, diabetes, gastrointestinal problems, hormonal therapies, oncology, musculoskeletal issues, and skin conditions. Its offerings also encompass eye care products, vitamin and mineral supplements, and intravenous fluids. These medications are supplied in a comprehensive array of dosage forms, such as solids, liquids, creams, ointments, suppositories, metered-dose and dry powder inhalers, nasal sprays, sterile injectables (including lyophilized forms), and large volume intravenous fluids. Beyond its own diverse portfolio, Beximco Pharmaceuticals provides contract manufacturing services to other companies and actively exports its products internationally.